These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 9499188

  • 1. Chemotherapy with methotrexate, carboplatin, mitoxantrone (Novantrone) and vincristine (Oncovin) in transitional-cell urothelial cancer.
    Pectasides D, Mylonakis A, Antoniou F, Kostopoulou M, Triantaphyllis D, Papadopoulou M, Varthalitis J, Dimitriadis M, Athanassiou A.
    Oncology; 1998; 55(2):139-44. PubMed ID: 9499188
    [Abstract] [Full Text] [Related]

  • 2. A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium.
    Small EJ, Fippin LJ, Ernest ML, Carroll PR.
    Cancer; 1996 Oct 15; 78(8):1775-80. PubMed ID: 8859191
    [Abstract] [Full Text] [Related]

  • 3. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
    Edelman MJ, Meyers FJ, Houston J, Lauder I.
    Semin Oncol; 1997 Oct 15; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
    [Abstract] [Full Text] [Related]

  • 4. Phase II study of a new combined primary chemotherapy regimen, intravenous methotrexate and vincristine and intraarterial adriamycin and cisplatin, for locally advanced urinary bladder cancer: preliminary results.
    Kuroiwa T, Naito S, Hasuo K, Kishikawa T, Masuda K, Kumazawa J.
    Cancer Chemother Pharmacol; 1995 Oct 15; 35(5):357-63. PubMed ID: 7850915
    [Abstract] [Full Text] [Related]

  • 5. Chemotherapy with methotrexate, vinblastine, epirubicin and carboplatin (Carbo-MVE) in transitional cell urothelial cancer. A Hellenic Co-Operative Oncology Group study.
    Skarlos DV, Aravantinos G, Linardou E, Kostakopoulos CA, Kastriotis I, Christodoulou C, Picramenos D, Giannakakis T, Dimopoulos K, Fountzilas G.
    Eur Urol; 1997 Oct 15; 31(4):420-7. PubMed ID: 9187901
    [Abstract] [Full Text] [Related]

  • 6. Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial.
    Boccardo F, Pace M, Guarneri D, Canobbio L, Curotto A, Martorana G.
    Cancer; 1994 Apr 01; 73(7):1932-6. PubMed ID: 8137220
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct 01; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Combination chemotherapy with methotrexate, vincristine, cisplatinum, cyclophosphamide, adriamycin, and bleomycin (MVP-CAB) for metastatic urothelial cancer].
    Fujii A, Oka N, Miyasaki S, Higuchi A, Itoh N, Okamoto Y, Tanaka H, Hiro-oka K, Shimatani N, Inoue T.
    Nihon Hinyokika Gakkai Zasshi; 1991 Jun 01; 82(6):932-9. PubMed ID: 1715415
    [Abstract] [Full Text] [Related]

  • 13. Carboplatin, methotrexate, and vinblastine in outpatients with advanced transitional cell carcinoma of the bladder.
    Pronzato P, Landucci M, Vaira F, Vigani A, Bertelli G.
    Am J Clin Oncol; 1995 Jun 01; 18(3):223-5. PubMed ID: 7747710
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term efficacy and safety outcomes of modified (simplified) MVAC (methotrexate/vinblastine/doxorubicin/cisplatin) as frontline therapy for unresectable or metastatic urothelial cancer.
    Necchi A, Mariani L, Giannatempo P, Raggi D, Farè E, Nicolai N, Piva L, Biasoni D, Catanzaro M, Torelli T, Stagni S, Maffezzini M, Pizzocaro G, De Braud FG, Gianni AM, Salvioni R.
    Clin Genitourin Cancer; 2014 Jun 01; 12(3):203-209.e1. PubMed ID: 24394493
    [Abstract] [Full Text] [Related]

  • 16. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
    Loehrer PJ, Einhorn LH, Elson PJ, Crawford ED, Kuebler P, Tannock I, Raghavan D, Stuart-Harris R, Sarosdy MF, Lowe BA.
    J Clin Oncol; 1992 Jul 01; 10(7):1066-73. PubMed ID: 1607913
    [Abstract] [Full Text] [Related]

  • 17. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
    Yamauchi T, Hida S, Ooishi K, Okada K, Yoshida O.
    Hinyokika Kiyo; 1985 Jul 01; 31(7):1093-104. PubMed ID: 2414981
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.
    Urology; 2004 Sep 01; 64(3):488-93. PubMed ID: 15351577
    [Abstract] [Full Text] [Related]

  • 20. Combination chemotherapy with carboplatin and methotrexate in the treatment of advanced urothelial carcinoma. A phase II study.
    Dogliotti L, Bertetto O, Berruti A, Clerico M, Fanchini L, Sicora W, Faggiuolo R.
    Am J Clin Oncol; 1995 Feb 01; 18(1):78-82. PubMed ID: 7847264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.